Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews
- 26 July 2022
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 78 (10) , 1567-1587
Abstract
Background Alzheimer’s disease (AD) is a neurodegenerative disease and the most common cause of dementia. In this umbrella systematic review (SR), we summarized the efficacy of different pharmacological interventions in improving cognitive function in patients with AD. Methods A systematic search was performed through the PubMed, Scopus, Embase, and Cochrane databases for SRs of studies assessing the efficacy of pharmacological interventions versus placebo in improving cognitive function in AD or mild cognitive impairment due to AD. The risk of bias (RoB) was assessed using the Risk of Bias in SRs (ROBIS) tool. Results Out of 1748 articles found through the database survey, 33 SR articles were included. These studies assessed effects of immunotherapy, cholinesterase inhibitors (ChEIs), memantine, statins, lithium, nonsteroidal anti-inflammatory drugs (NSAIDs), antidiabetic agents, Cerebrolysin, RAS-targeting antihypertensive drugs (ARBs and ACEIs), psychostimulants, glycogen synthase kinase 3 (GSK-3) inhibitors, melatonin, and herbal medications on cognitive function in AD patients. There was no notable overall RoB in 18 studies (54.5%), the RoB in 14 studies (42.4%) was high, and in one study (3.0%) it was unclear. Conclusions The use of ChEIs, including rivastigmine, galantamine, and donepezil, as well as memantine has demonstrated a positive impact on improving cognitive outcomes of AD patients, but no considerable effects were found for immunotherapies. Melatonin, statins, antihypertensive drugs, antidiabetic agents, Cerebrolysin, psychostimulants, and some herbal drugs such as Danggui-Shaoyao-San and Ginkgo biloba seem to be effective in improving cognitive function of AD patients, but the evidence in this regard is limited.Keywords
Funding Information
- Tabriz University of Medical Sciences (grant number: 66147)
This publication has 111 references indexed in Scilit:
- Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer’s DiseasePLOS ONE, 2013
- LTP requires a reserve pool of glutamate receptors independent of subunit typeNature, 2012
- Assessment scales in dementiaTherapeutic Advances in Neurological Disorders, 2012
- Herbal therapy: a new pathway for the treatment of Alzheimer's diseaseAlzheimer's Research & Therapy, 2010
- Does lithium protect against dementia?Bipolar Disorders, 2010
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes ScoresArchives of Neurology, 2008
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008
- MemantineDrugs, 2006
- The Use of Herbal Medicine in Alzheimer′s Disease—A Systematic ReviewEvidence-Based Complementary and Alternative Medicine, 2006
- The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug DevelopmentThe Journal of Pharmacology and Experimental Therapeutics, 2003